Chronic kidney disease: Psychosocial impact of chronic pain

Geriatrics

Volumn 62, Issue 2, 2007, Pages 17-23

  Davison, Sara N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Chronic kidney disease; Depression; Dialysis; Health related quality of life

Indexed keywords

LITHIUM; OPIATE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIA; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC PAIN; CLINICAL FEATURE; CLINICAL PROTOCOL; DEPRESSION; HIGH RISK POPULATION; HUMAN; MENTAL DISEASE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PSYCHIATRIC DIAGNOSIS; PSYCHOSOCIAL ENVIRONMENT; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; SINGLE DRUG DOSE; UNITED STATES; WELLBEING;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; GERIATRICS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; PAIN; PSYCHOSOCIAL DEPRIVATION; QUALITY OF LIFE; RENAL DIALYSIS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 33847115649     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41(1):1-12.
2. U.S.Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: U.S. Renal Data System, 2005.
3. Davison SN, Jhangri GS, Johnson JA. Cross sectional validity of a modified Edmonton Symptom Assessment System (ESAS) in dialysis patients: A simple assessment of symptom burden. Kidney Int 2006; 69(9):1621-5.
4. Davison SN. Pain in hemodialysis patients: Prevalence, cause, severity, and management. Am J Kidney Dis 2003; 42(6):1239-47.
5. Weisbord SD, Fried LF, Arnold RM, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol 2005; 16(8):2487-94.
6. Cohen LM, Germain M, Poppel DM, Woods A, Kjellstrand CM. Dialysis discontinuation and palliative care. Am J Kidney Dis 2000; 36(1):140-4.
7. Merkus MC Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT. Physical symptoms and quality of life in patients on chronic dialysis: Results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD). Nephrol Dial Transplant 1999; 14(5):1163-70.
8. Davison SN, Jhangri GS, Johnson JA. Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients. Nephrol Dial Transplant 2006; 21(11):3189-95.
9. Finkelstein FO, Finkelstein SH. Depression in chronic dialysis patients: assessment and treatment. Nephrol Dial Transplant 2000; 15(12):1911-3.
10. Wilson KG, Eriksson MY, D'Eon JL, Mikail SF, Emery PC. Major depression and insomnia in chronic pain. Clin J Pain 2002; 18(2):77-83.
11. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 1997; 13(2):116-37.
12. Davison SN, Jhangri GS. The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients. J Pain Symptom Manage 2005; 30(5):465-73.
13. O'Donnell K, Chung JY. The diagnosis of major depression in end-stage renal disease. Psychother Psychosom 1997; 66(1):38-43.
14. Smith MD, Hong BA, Robson AM. Diagnosis of depression in patients with end-stage renal disease. Comparative analysis. Am J Med 1985; 79(2):160-6.
15. Kimmel PL, Peterson RA, Weihs KL, et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 2000; 57(5):2093-8.
16. Lopes AA, Bragg J, Young E, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 2002; 62(1):199-207.
17. Fabrazzo M, De Santo RM. Depression in chronic kidney disease. Semin Nephrol 2006; 26(1):56-60.
18. Chambers EJ, Germain M, Brown E, eds. Supportive Care for the Renal Patient. New York, NY: Oxford University Press, 2004.
19. Magni G, Rossi MR, Rigatti-Luchini S, Merskey H. Chronic abdominal pain and depression. Epidemiologic findings in the United States. Hispanic Health and Nutrition Examination Survey. Pain 1992; 49(1):77-85.
20. Gatchel RJ. Psychological disorders and chronic pain: Cause and effect relationships. In: Gatchel RJ, Turk DC, eds. Psychological Approaches to Pain Management: A Practitioner's Handbook. New York: Guilford Publications, 1996:33-54.
21. Hurwitz EL, Goldstein MS, Morgenstern H, Chiang LM. The impact of psychological factors on neck pain and disability outcomes among primary care patients: Results from the UCLA Neck Pain Study. Disabil Rehabil 2006; 28(21):1319-29.
22. Burns JW, Johnson BJ, Mahoney N, Devine J, Pawl R. Cognitive and physical capacity process variables predict long-term outcome after treatment of chronic pain. J Consult Clin Psychol 1998; 66(2):434-9.
23. Davison SN. Chronic pain in end-stage renal disease. Adv Chronic Kidney Dis 2005; 12(3):326-34.
24. Craven JL, Rodin GM, Littlefield C. The Beck Depression Inventory as a screening device for major depression in renal dialysis patients. Int J Psychiatry Med 1988; 18(4):365-74.
25. Kimmel PL. Psychosocial factors in dialysis patients. Kidney Int 2001; 59(4):1599-613.
26. Tossani E, Cassano P, Fava M. Depression and renal disease. Semin Dial 2005; 18(2):73-81.
27. Turk S, Atalay H, Altintepe L, et al. Treatment with antidepressive drugs improved quality of life in chronic hemodialysis patients. Clin Nephrol 2006; 65(2):113-8.
28. Cohen LM, Germain M, Tessier EG. Neuropsychiatric complications and psychopharmacology of end-stage renal disease. In: Brady HR, Wilcox CS, eds. Therapy of Nephrology and Hypertension, 2nd ed. A Companion to Brenner and Rector's The Kidney. Philadelphia, PA. WB Saunders, 2003:731-46.
29. Blumenfield M, Levy NB, Spinowitz B, et al. Fluoxetine in depressed patients on dialysis. Int J Psychistry Med 1997; 27(1):71-80.
30. McEvoy G, ed. AHFS Drug Information 2000. Bethesda, MD: American Society of Health-System Pharmacists, 2000.
31. Aronoff GR, Berns JS, Brier ME, et al. Drug prescribing in renal failure: Dosing Guidelines for Adults, 4th ed. Philadelphia, PA: American College of Physicians, 1999.
32. Troy SM, Schultz RW, Parker VD, Chiang ST, Blum RA. The effect of renal disease on the disposition of venlafaxine. Clin Pharmacol Ther 1994; 56(1):14-21.
33. Port FK, Kroll PD, Rosenzweig J. Lithium therapy during maintenance hemodialysis. Psychosomatics 1979; 20(2):130-2.